Cancer Stem Cell Culture Gel Substrate
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods fail to effectively culture and maintain cancer stem cells due to their instability and chemoresistance, making it difficult to eradicate them and screen anti-cancer drugs effectively.
Innovation Solution
A cell culture substrate in the form of a gel comprising a conjugate of glycosaminoglycan and substituted phenalkylamine is used to selectively culture and maintain cancer stem cells, allowing for their separation and drug screening by controlling the stiffness and crosslink density of the gel to promote growth and chemoresistance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cell culture methods are used, then cancer stem cells can be cultured, but they remain unstable and difficult to maintain due to chemoresistance
Solution Approach 1:
The patent changes the physical-chemical parameters of the cell culture substrate by using a hydrogel with specific stiffness (matching tissue mechanics) and incorporating integrin-binding peptides (RGD sequences). These parameter changes create a controlled microenvironment that maintains cancer stem cell identity and reduces chemoresistance, thereby improving culture stability and overcoming the harmful effects of chemoresistance.
Solution Approach 2:
The patent employs a composite hydrogel substrate combining natural extracellular matrix components (such as collagen, fibronectin, or laminin) with synthetic polymers. This composite material provides both the mechanical properties (stiffness) and biochemical signals (integrin-binding sites) necessary for stable cancer stem cell culture, while the controlled environment helps mitigate chemoresistance through enhanced drug penetration and altered cell behavior.
2Ease of operation
If conventional cell culture substrates are used, then cell culture is simple, but cancer stem cells cannot be selectively cultured or separated
Solution Approach 1:
The patent applies local quality by incorporating specific integrin-binding peptide sequences (RGD motifs) at particular locations within the hydrogel substrate. This localized biochemical functionality enables selective interaction with cancer stem cells that express specific integrins, allowing selective culturing and separation while maintaining overall operational simplicity. The selective binding occurs at the local interface between the substrate and cell surface receptors.
3Productivity
If gel stiffness is increased to promote cancer stem cell growth, then cell propagation is enhanced, but chemoresistance may be affected
Solution Approach 1:
The patent optimizes the stiffness parameter of the hydrogel substrate to match the mechanical properties of native tissue environments where cancer stem cells reside. This specific stiffness range promotes cancer stem cell propagation and self-renewal while simultaneously creating a microenvironment that is more susceptible to chemotherapeutic agents. The controlled stiffness parameter thus enhances productivity without excessively worsening chemoresistance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables stable culture and separation of cancer stem cells, enhancing their viability and resistance to chemotherapeutic drugs, facilitating effective drug screening and potential therapeutic approaches.
Implementation Method 1
cancer stem cells that contain a marker that interacts with the glycosaminoglycan may be selectively cultured on the gel
Implementation Method 2
The stiffness or crosslink density of the gel may be altered in order to promote the growth and maintenance of the cancer stem cells or cancer cell line
Data Source
Figure 1~2(b)
Figure 3(a)~4(b)
Figure 5
AI summary
There is provided a method for culturing a population of cancer stem cells. The method comprises introducing the cancer stem cells on or in a cell culture substrate, the cell culture substrate being in the form of a gel comprising a conjugate of a glycosaminoglycan and a substituted phenalkylamine.